Allspring Global Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$332M Buy
347,557
+11,676
+3% +$11.8M 0.56% 33
2025
Q4
$363M Buy
335,881
+16,888
+5% +$16.1M 0.59% 25
2025
Q3
$263M Buy
318,993
+197,315
+162% +$147M 0.42% 46
2025
Q2
$94.4M Sell
121,678
-1,977
-2% -$1.54M 0.16% 159
2025
Q1
$99.6M Sell
123,655
-3,901
-3% -$3.25M 0.17% 140
2024
Q4
$99.2M Sell
127,556
-280,938
-69% -$233M 0.16% 153
2024
Q3
$362M Buy
408,494
+39,581
+11% +$35.6M 0.56% 28
2024
Q2
$334M Sell
368,913
-13,675
-4% -$10.9M 0.54% 27
2024
Q1
$298M Buy
382,588
+94,091
+33% +$67M 0.46% 38
2023
Q4
$168M Buy
288,497
+63,451
+28% +$37M 0.28% 77
2023
Q3
$121M Buy
225,046
+27,111
+14% +$14M 0.21% 108
2023
Q2
$92.8M Buy
197,935
+89,581
+83% +$37.6M 0.15% 169
2023
Q1
$37.2M Buy
108,354
+8,434
+8% +$2.84M 0.06% 416
2022
Q4
$36.6M Sell
99,920
-20,225
-17% -$7.17M 0.06% 408
2022
Q3
$38.8M Buy
120,145
+31,249
+35% +$9.9M 0.07% 370
2022
Q2
$28.8M Sell
88,896
-84,210
-49% -$25.3M 0.05% 480
2022
Q1
$49.6M Sell
173,106
-78,580
-31% -$20.2M 0.06% 379
2021
Q4
$69.5M Buy
+251,686
New +$63.8M 0.08% 335

Other funds holding LLY

Allspring Global Investments's LLY Position: Q1 2026 in Review

Allspring Global Investments increased its Eli Lilly (LLY) stake by 3.5% in Q1 2026, buying an estimated $11.8M and bringing the position to 347,557 shares worth $332M. The position accounts for 0.56% of the portfolio, ranked #33.

Allspring Global Investments first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $363M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Allspring Global Investments held 347,557 shares of Eli Lilly worth $332M as of Q1 2026.
  • Allspring Global Investments bought 11,676 Eli Lilly shares in Q1 2026, an estimated $11.8M.
  • Eli Lilly made up 0.56% of Allspring Global Investments's portfolio in Q1 2026, its #33 holding.
  • Allspring Global Investments first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Eli Lilly position peaked at $363M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.